Livia Casciola-Rosen
Overview
Explore the profile of Livia Casciola-Rosen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
3094
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tiniakou E, Casciola-Rosen L, Thomas M, Manabe Y, Antar A, Damarla M, et al.
Clin Transl Immunology
. 2024 Dec;
13(12):e70019.
PMID: 39734590
Objectives: CD209L and its homologous protein CD209 act as alternative entry receptors for the SARS-CoV-2 virus and are highly expressed in the virally targeted tissues. We tested for the presence...
2.
McMahan Z, Casciola-Rosen L, Kaniecki T, Gutierrez-Alamillo L, Ming S, Seika P, et al.
medRxiv
. 2024 Dec;
PMID: 39649583
Background: Most patients with systemic sclerosis (SSc) experience gastrointestinal (GI) dysmotility. The enteric nervous system (ENS) regulates GI motility, and its dysfunction causes dysmotility. A subset of SSc patients harbor...
3.
Fiorentino D, Casciola-Rosen L
Curr Opin Rheumatol
. 2024 Nov;
36(6):427-429.
PMID: 39584404
No abstract available.
4.
McMorrow F, Wedderburn L, Chinoy H, Oldroyd A, Lamb J, Rider L, et al.
Rheumatology (Oxford)
. 2024 Nov;
PMID: 39514366
Objectives: Anti-TIF1γ autoantibodies are associated with malignancy in adult-onset idiopathic inflammatory myopathy (IIM) and this risk is attenuated if patients are also positive for anti-specificity protein 4 (Sp4) or anti-cell...
5.
Mecoli C, Fiorentino D, Albayda J, Paik J, Tiniakou E, Adler B, et al.
ACR Open Rheumatol
. 2024 Oct;
6(12):912-917.
PMID: 39370373
Objective: The objective of this study was to describe the frequency, co-occurrence, and cancer association of anti-cell division cycle and apoptosis regulator 1 (anti-CCAR1) and anti-Sp4 in two large independent...
6.
Orbai A, Fiorentino D, Perin J, Darrah E, Yang Q, Gutierrez-Alamillo L, et al.
ACR Open Rheumatol
. 2024 Sep;
6(12):807-819.
PMID: 39218617
Objective: Adaptive immunity mediates psoriatic disease pathogenesis. We aimed to identify novel psoriatic autoantigens and their phenotypic associations in deeply characterized patient cohorts. Methods: Sera from psoriatic arthritis (PsA) patients...
7.
Kuchinad K, Kim J, Woods A, Leatherman G, Gutierrez-Alamillo L, Mayes M, et al.
Ann Rheum Dis
. 2024 Jul;
83(11):1513-1521.
PMID: 39019570
Objective: To understand if autoantibodies account for racial variation in disease severity, we compared autoantibody distribution and associated phenotype between self-identified black and white systemic sclerosis (SSc) patients. Methods: 803...
8.
McMahan Z, Kulkarni S, Andrade F, Perin J, Zhang C, Hooper J, et al.
Arthritis Rheumatol
. 2023 Aug;
76(1):92-99.
PMID: 37530745
Objective: Autoantibodies are clinically useful in phenotyping patients with systemic sclerosis (SSc). Gastrointestinal (GI) function is regulated by the enteric nervous system (ENS) and commonly impaired in SSc, suggesting that...
9.
Kim J, Woods A, Gutierrez-Alamillo L, Laffoon M, Wigley F, Hummers L, et al.
Arthritis Rheumatol
. 2023 Jul;
76(1):68-77.
PMID: 37488962
Objectives: We examined whether an array of scleroderma autoantibodies associates with risk of cancer and could be useful tools for risk stratification. Methods: Scleroderma cancer cases and scleroderma controls without...
10.
Antiochos B, Casciola-Rosen L
Front Med (Lausanne)
. 2023 May;
10:1165225.
PMID: 37228405
Interferon (IFN) is a key component of the innate immune response. For reasons that remain incompletely understood, the IFN system is upregulated in several rheumatic diseases, particularly those that feature...